FTC sues main pharmacy profit professionals in excess of insulin costs The company introduced motion in opposition to Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the record price of existence-conserving insulin prescription drugs. The offer must be completed by Sept. 30 or https://arizonahardteanutritionfa27271.xzblogs.com/71851332/the-smart-trick-of-healthcare-news-that-nobody-is-discussing